Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Laksmi Hartajanie

Laksmi Hartajanie

Diponegoro University, Indonesia

Title: Fermented bitter melon juice as complimentary promising agent for diabetes type-2 treatment

Biography

Biography: Laksmi Hartajanie

Abstract

Momordica charantia (Bitter melon) contains substance with antidiabetic properties such as charantin that has anti-oxidative properties. Oxidative stress plays a major role in the pathogenesis and progression of metabolic syndrome such as diabetes. In the present study, a total of 30 male Sprague-Dawley rats were used. Diabetes type-2 was induced by a single dose (60 mg/kg) of Streptozotocin (STZ), intravenous injection. Following three days of STZ induction, the animals were randomly divided into five groups (n=6); diabetic group treated with Acarbose 40 mg/100 g feed (DM-Ac), diabetic group treated with MC (DM-MC), diabetic group treated with Probiotic 1 MC (DM-PMC1), diabetic group treated with probiotic 2 MC (DM-PMC2) and diabetic untreated group (DM-Ctrl). Oral administration of the MC fruit extract (10 ml/kg body weight) was continued for 28 days. All groups treated with MC (non-fermented and fermented) showed a significant decreased (P<0.05) in fasting blood glucose and post prandial blood glucose compared to the DM-Ctrl group. SOD level was significantly increased in MC groups. These results suggest that fermented bitter melon juice is a promising complimentary agent for diabetes type-2 treatment.